Cases 1 - 4 of 4
In re: Mylan Inc. et al
as 1:2022mc00501
Petitioner:
Mylan Inc. and Mylan Pharmaceuticals Inc.
Respondent:
Somaxon Pharmaceuticals Inc., Procom One Inc., Currax Pharmaceuticals LLC and others
In re: Somaxon Pharmaceuticals Inc
as 1:2022mc00275
Respondent:
Somaxon Pharmaceuticals Inc., Currax Pharmaceuticals LLC, Currax Holdings LLC and others
Petitioner:
Mylan Inc. and Mylan Pharmaceuticals Inc.
MYLAN INC. et al v. SOMAXON PHARMACEUTICALS, INC. et al
as 2:2022cv03944
Petitioner:
MYLAN INC. and MYLAN PHARMACEUTICALS INC.,
Plaintiff:
SOMAXON PHARMACEUTICALS, INC. and PROCOM ONE INC.
Respondent:
Currax Pharmaceuticals LLC, Currax Holdings LLC and Currax Holdings USA LLC
Interested Party:
PAR PHARMACEUTICAL INC, ACTAVIS ELIZABETH LLC, ACTAVIS INC. and others
Cause Of Action: 28 U.S.C. ยง 1338 Patent Infringement
Somaxon Pharmaceuticals Inc. v. Actavis Elizabeth LLC
as 20-2074
Plaintiff / Appellant:
PROCOM ONE INC., CURRAX HOLDINGS LLC, SOMAXON PHARMACEUTICALS INC. and others
Defendant / Appellee:
ACTAVIS INC., ACTAVIS ELIZABETH LLC, MYLAN INC. and others
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
